Diabetic retinopathy: research to clinical practice
- PMID: 29075511
- PMCID: PMC5648499
- DOI: 10.1186/s40842-017-0047-y
Diabetic retinopathy: research to clinical practice
Abstract
Background: Diabetic Retinopathy (DR) is a leading cause of visual impairment in the United States. The CDC estimates that the prevalence of DR will triple from 2005 to 2050.
Main body: The report summarizes major past advances in diabetes research and their impact on clinical practice. Current paradigms and future directions are also discussed.
Conclusions: DR is a leading cause of visual impairment in the US. Significant progress has been made in the understanding and treatment of DR, but rising prevalence demands innovative approaches to management in the future.
Keywords: Diabetic retinopathy.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous